Topics

PubMed Journal Database | Diabetes research and clinical practice RSS

23:18 EST 18th November 2019 | BioPortfolio

The US National Library of Medicine and National Institutes of Health manage PubMed.gov which comprises of more than 29 million records, papers, reports for biomedical literature, including MEDLINE, life science and medical journals, articles, reviews, reports and  books.

BioPortfolio aims to cross reference relevant information on published papers, clinical trials and news associated with selected topics - speciality.

For example view all recent relevant publications on Epigenetics and associated publications and clincial trials.

Showing PubMed Articles 1–25 of 726 from Diabetes research and clinical practice

Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients.

To compare basal insulin and mTOR signaling in subcutaneous fat of obese T2DM vs. obese subjects with normal glucose tolerance (NGT), and correlate it with clinical parameters of carbohydrate metabolism and incretin secretion profiles.

Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: a systematic review and meta-analysis of randomized controlled trials.

Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are now considered as key players in the treatment of type 2 diabetes mellitus (T2DM). The purpose of this meta-analysis was to provide precise effect estimates regarding the safety and efficacy of the addition of a GLP-1RA on top of SGLT-2i treatment.

The impact of maternal weight in pregnancy on glucose metabolism in non-diabetic offspring in late adulthood.

We aimed to examine the association between maternal adiposity and glucose metabolism in adult offspring without diabetes, simultaneous taking offspring own adiposity into account.

Glycemic Control Outcomes of Adults Using the MiniMedTM 670G Hybrid Closed-Loop (HCL) System: A Single-Center Study.

MiniMed 670G hybrid closed-loop (HCL) insulin pump system offers Auto Mode basal insulin delivery based on patient's sensor glucose readings. The primary outcome of this study is to determine the correlation between Time in Auto Mode and Sensor Glucose Time in Range (SG-TIR) of 70-180 g/dL. Other secondary outcomes focusing on pump behavior characteristics were also assessed.

Beyond basal-bolus insulin regimen: is it still the ultimate chance for therapy in diabetes?

Meal-time + basal insulin therapy: is all not well?

Waist-height ratio: How well does it predict glucose intolerance and systemic hypertension?

The aim of this study is to assess whether WHtR is a better predictor of glucose intolerance and systemic hypertension than some other obesity indices.

The relationship between glucose variability and insulin sensitivity and oxidative stress in subjects with prediabetes.

The present study assessed the relationship between glucose variability (GV) and insulin levels, insulin resistance and oxidative stress at early stages of glucose intolerance.

Screening for Gestational Diabetes Mellitus- can we use the 50-g glucose challenge test of the previous pregnancy?

To assess the association between previous pregnancy glucose challenge test (GCT) result among non-diabetic women and the rate for gestational diabetes mellitus (GDM) in the subsequentpregnancy.

Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: a nationwide cohort study.

To characterise the patterns of switching, adherence, and persistence among adults aged ≥18 years with diabetes prescribed dipeptidyl peptidase-4 inhibitors (DPP-4is) in Australia.

Serum calcification propensity in type 1 diabetes associates with mineral stress.

Increased vascular calcification could be an underlying mechanism of cardiovascular complications in type 1 diabetes mellitus (T1DM). Calcificationpropensitycan be monitored by the maturation time of calciprotein particles in serum (T test). A high calcification propensity (i.e. low T-value) is an independent determinant of mortality in various populations. Aim was to investigate Tlevels with indices of calcium metabolism and disease status in T1DM patients.

Excessive gestational weight gain and the risk of gestational diabetes: Comparison of Intergrowth-21 standards, IOM recommendations and a local reference.

To compare the abilities of Intergrowth-21 standards, Institute of Medicine (IOM) recommendations and a Chinese reference on gestational weight gain (GWG) to identify women at risk of gestational diabetes (GDM) and GDM-related adverse outcomes.

Hypoglycemia and antihyperglycemic treatment in adult MODY patients - a systematic review of literature.

Maturity onset diabetes of the young (MODY) is a heterogeneous group of diseases caused by a single mutation in one of the 14 genes involved in the regulation of glucose homeostasis. GCK, HNF1A, and HNF4A genes are among the most common genes affected. Expression of these genes in the key organs for defense against hypoglycemia and their participation in counter-regulation to hypoglycemia may potentially put individuals with a heterozygous mutation in these genes at increased risk for hypoglycemia. In HNF4A...

Real-life experience with Dulaglutidae: Analysis of clinical effectiveness to 24 months.

Dulaglutide is an agonist of "glucagon-like peptide type 1" receptors (arGLP1). The clinical efficacy of this molecule is based on reductions in glycosylated hemoglobin (HbA1c) and weight and the number of hypoglycemia, data shown in the pivotal AWARD studies.

Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes.

Thyroid dysfunction is a risk factor for cardiovascular disease. Whether thyroid function within the normal range is a risk factor for cardiovascular disease remains uncertain. The aim of this study is to evaluate whether plasma thyroid-stimulating hormone (TSH) levels in the normal range are a risk factor for cardiovascular disease and mortality in participants with type 2 diabetes mellitus with high cardiovascular risk.

Body surface area and glucose tolerance - the smaller the person, the greater the 2-hour plasma glucose.

The oral glucose tolerance test (OGTT) is standardized globally with a uniform glucose load of 75 g to all adults irrespective of body size. An inverse association between body height and 2-hour postload plasma glucose (2hPG) has been demonstrated. Our aim was to evaluate the relationship between body surface area (BSA) and plasma glucose values during an OGTT.

Metformin Lactic Acidosis: should we still be afraid?

Metformin, the first choice drug for type 2 diabetes treatment in all stages of therapy, and one of the most widely prescribed anti-hyperglycemic agent worldwide, represents a rare example of an old drug which continues to display new beneficial effects in various fields. However, lactic acidosis (LA) persists as a serious adverse effect. LA incidence is low and is not necessarily determined by the administration of metformin. Unfortunately, the concern for this complication has negatively affected the drug...

Trace elements in saliva and plasma of patients with type 2 diabetes: Association to metabolic control and complications.

An analysis is made of the saliva and plasma levels of trace elements in patients with type 2 diabetes mellitus and their association to metabolic control and the presence of chronic complications.

The impact of provision of self-monitoring of blood glucose supplies on self-care activities among patients with uncontrolled Type 2 diabetes mellitus: A prospective study.

Self-monitoring of blood glucose (SMBG) is an important self-care activity for patients with Type 2 diabetes mellitus (T2DM) to achieve glycaemic control. The aim of this study was to evaluate the impact of providing SMBG supplies on self-care among patients with uncontrolled T2DM.

Short term optimization of glycaemic control using insulin improves sympatho-vagal tone activities in patients with type 2 diabetes.

Diabetic cardiac autonomic neuropathy (CAN) is potentially life threatening and its severity might further be aggravated by poor glycaemic control. A decrease in Heart rate variability (HRV) is the earliest finding of CAN even at the sub clinical stage. While intensive glycaemic control prevents the development of CAN in patients with type 1 diabetes, it is not known whether the intensification of glycaemic control using insulin would improve cardiovascular autonomic functions in type 2 diabetes patients. T...

Birth outcomes in women with gestational diabetes managed by lifestyle modification alone: The PANDORA Study.

To assess outcomes of women in the Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) cohort with gestational diabetes mellitus (GDM) managed by lifestyle modification compared with women without hyperglycaemia in pregnancy.

Ipragliflozin as an add-on therapy in type 2 diabetes mellitus patients: an evidence-based pharmacoeconomics evaluation.

To evaluate the efficacy, safety and cost-effectiveness of ipragliflozin as an add-on therapy in patients with type 2 diabetes mellitus (T2DM).

Risk of macrovascular complications in statin-treated patients developing diabetes.

To assess the risk of macrovascular complications in patients developing diabetes from statin treatment.

Hospital Admissions for Hyperglycemic Emergencies in Young Adults at an Inner-City Hospital.

There is limited information characterizing young adults (18-35 years) (YA) with diabetes, especially those admitted for hyperglycemic emergencies. The study aims were to examine associations of patient-level characteristics with hyperglycemic emergency hospitalization and to identify variations based on diabetes type and glycemic control.

Does control of glycemia regulate immunological parameters in insulin-treated persons with type 1 diabetes?

We investigated the relationships between control of glycemia and the frequencies of immune cell subpopulations and also the profile of circulating T cell cytokines in insulin-treated persons with type 1 diabetes (T1D).


Quick Search